Target intelligence / Profile preview

Brain-specific homeobox protein homolog (BSX)

Target
BSX
Molecular classification
Transcription factor, Homeodomain protein, ANTP-class homeobox gene
01

Overview

Brain-specific homeobox protein homolog (BSX) is an evolutionarily conserved homeodomain-containing transcription factor of the ANTP class, essential for the development and function of specific brain regions including the pineal gland, hypothalamic nuclei (notably the arcuate nucleus), telencephalic septum, and mammillary bodies[1][2][3][5][7]. In mice and zebrafish, BSX critically regulates neuronal differentiation, particularly of pineal photoreceptor cells and hypothalamic neurons that control key neuropeptides affecting energy balance (Agouti-related peptide, Neuropeptide Y). In the pineal gland, BSX is involved in regulating circadian gene expression and the development of melatonin-producing cells[1][3]. Mutations and altered expression patterns are associated with certain developmental syndromes (e.g., Jacobsen syndrome), but there is no evidence that BSX functions as a druggable target or established disease biomarker[5][6]. BSX acts upstream of or within the transcriptional regulatory networks defining neural tissue identity and differentiation[4][5][6].

Other names
BSXBSX1Brain‐specific homeobox protein homologBsx (mouse, lower case gene/protein naming)
02

Mechanism of action

Not applicable

03

Biological functions

Transcriptional regulationRegulation of neuronal/neuropeptide expressionCell differentiationRegulation of hypothalamic orexigenic peptides (Agouti-related peptide, Neuropeptide Y)Development of specific brain regions (pineal gland, arcuate nucleus, septum, mammillary bodies)Circadian rhythm control in the pineal gland in some species
04

Disease associations

Jacobsen syndrome (associated disease, not a direct driver)Altered energy balance/metabolic disorders (via hypothalamic function)Other (no predominant cancer, inflammatory, or neurodegenerative role directly tied to BSX in humans has been reported)
05

Safety considerations

Not applicable
06

Interacting drugs

None known
07

Biomarkers

None established

Beyond the preview

Go deeper on Brain-specific homeobox protein homolog (BSX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain-specific homeobox protein homolog (BSX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call